SCHEMBL526278

SCHEMBL526278

CCOCCON=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9954026 0.97 KMT2A (0.52)
SCHEMBL525604 0.97 KMT2A (0.52)
SCHEMBL9954593 0.97 KMT2A (0.52)
SCHEMBL9304758 0.81
SCHEMBL2968811 0.78
SCHEMBL9304699 0.77 TSHR (0.50)
SCHEMBL10494077 0.77 TSHR (0.50)
SCHEMBL19970453 0.74 ALDH1A1 (0.60)
SCHEMBL22247 0.74
SCHEMBL295737 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2849795-A1 NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE Baxter International Inc (US) 2015-03-25 EP claimed
EP-2849794-A1 NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE AND USE OF NMR ANALYSES OF THE SAME Baxter International Inc (US) 2015-03-25 EP claimed
WO-2013173557-A1 NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE AND USE OF NMR ANALYSES OF THE SAME BAXTER INTERNATIONAL INC. (US) 2013-11-21 WO claimed
WO-2013173543-A1 NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE BAXTER INTERNATIONAL INC. (US) 2013-11-21 WO claimed
EP-2654794-A1 MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN Baxter International Inc (US) 2013-10-30 EP claimed
EP-2598172-A1 NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE Baxter International Inc (US) 2013-06-05 EP claimed
WO-2012087838-A1 MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN BAXTER INTERNATIONAL INC. (US) 2012-06-28 WO claimed
EP-2459224-A2 BLOOD COAGULATION PROTEIN CONJUGATES Baxter International Inc (US) 2012-06-06 EP claimed
EP-2459226-A2 GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS Lipoxen Technologies Limited (GB) 2012-06-06 EP claimed
WO-2012016131-A1 NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE BAXTER INTERNATIONAL INC. (US) 2012-02-02 WO claimed
WO-2011012850-A9 GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS LIPOXEN TECHNOLOGIES LIMITED (GB) 2011-05-12 WO claimed
WO-2011017055-A2 BLOOD COAGULATION PROTEIN CONJUGATES BAXTER INTERNATIONAL INC. (US) 2011-02-10 WO claimed
WO-2011012850-A2 GLYCOPOLYSIALYLATION OF NON-BLOOD COAGULATION PROTEINS LIPOXEN TECHNOLOGIES LIMITED (GB) 2011-02-03 WO claimed
EP-3383895-A1 FACTOR VIII WITH EXTENDED HALF-LIFE AND REDUCED LIGAND-BINDING PROPERTIES Baxalta Incorporated (US) 2018-10-10 EP disclosed
WO-2017096383-A1 FACTOR VIII WITH EXTENDED HALF-LIFE AND REDUCED LIGAND-BINDING PROPERTIES BAXALTA INCORPORATED (US) 2017-06-08 WO disclosed
EP-2849794-A1 NUCLEOPHILIC CATALYSTS FOR OXIME LINKAGE AND USE OF NMR ANALYSES OF THE SAME Baxter International Inc (US) 2015-03-25 EP disclosed
US-5328993-A Dyeing plastics; colorfastness, photostability BAYER AKTIENGESELLSCHAFT (DE) 1994-07-12 US disclosed
US-4288362-A Monoazo pigments containing a quinazo linonylacetoacetanilide coupling component BAYER AKTIENGESELLSCHAFT (DE) 1981-09-08 US disclosed
US-4260540-A SPIN DYEING POLYACRYLONITRILE BAYER AKTIENGESELLSCHAFT (DE) 1981-04-07 US disclosed
US-4225489-A Heterocyclic azo dyes and pigments containing 4-quinazolinone moieties BAYER AKTIENGESELLSCHAFT (DE) 1980-09-30 US disclosed